AcroViz Axonal Brain Age examination service is the first-to-market medical SaaS (Software as a Service) for brain health, which provides accurate and objective assessment that evaluate cognitive decline before symptoms appear, allowing timely effective intervention to prevent dementia.

Aging of brain involves changes in neurons and axons that lead to the decline of cognitive functions. AcroViz develops novel age-based dementia grading and predicting model by examining microscopic brain axonal integrity. The technology has demonstrated that brain predicted age difference (PAD), i.e. Axonal Brain Age contrasted with the individuals’ chronological ages, is able to predict clinical dementia rating change.

AcroViz has deployed this unique service to cloud platform for its elasticity. The brain health examination provides the Axonal Brain Age of whole brain fiber tracts, and eight cognitive function networks highly related to dementia, including long-term episodic memory & emotion, long-term semantic memory network, long-term semantic memory network, working memory, attention, language, visual and sensorimotor networks.

AcroViz’s technology is able to offer more specific and complete evaluation of brain axon degeneration to doctors, drug developers, care givers and individuals for better monitoring and treatment decision. AcroViz works with clinics and hospitals for preventive health-check, as well as pharma or medical device companies on various clinical studies.